Literature DB >> 32735964

Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression.

Zhenyu Liao1, Wang Jiang1, Longyun Ye1, Tianjiao Li1, Xianjun Yu2, Liang Liu3.   

Abstract

Although the eukaryotic genome is mainly comprised of linear chromosomal DNA, genes can also be found outside of chromosomes. The unconventional presence of extrachromosomal genes is usually found to be circular, and these structures are named extrachromosomal circular DNA (eccDNA), which are often observed in cancer cells. Various types of eccDNA including small polydispersed DNA (spcDNA), telomeric cirlces, microDNA, etc. have been discovered. Among these eccDNA, extrachromosomal DNA (ecDNA), which encompasses the full spectrum of large, gene-containing extrachromosomal particles, has regained great research interest due to recent technological advances such as next-generation sequencing and super-resolution microscopy. In this review, we summarize the different types of eccDNA and discuss the role of eccDNA, especially ecDNA in tumor heterogeneity and progression. Additionally, we discuss some possible future investigative directions related to ecDNA biogenesis and its clinical application.
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biogenesis; Extrachromosomal DNA; Micronuclei; Oncogene amplification; Tumor heterogeneity; eccDNA

Mesh:

Substances:

Year:  2020        PMID: 32735964     DOI: 10.1016/j.bbcan.2020.188392

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  20 in total

Review 1.  New insights of extrachromosomal DNA in tumorigenesis and therapeutic resistance of cancer.

Authors:  Hui Qiu; Zhi-Ying Shao; Xin Wen; Long-Zhen Zhang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  MicroDNA levels are dependent on MMEJ, repressed by c-NHEJ pathway, and stimulated by DNA damage.

Authors:  Teressa Paulsen; Pumoli Malapati; Yoshiyuki Shibata; Briana Wilson; Rebeka Eki; Mouadh Benamar; Tarek Abbas; Anindya Dutta
Journal:  Nucleic Acids Res       Date:  2021-11-18       Impact factor: 16.971

Review 3.  The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.

Authors:  Eric van Leen; Lotte Brückner; Anton G Henssen
Journal:  Nat Genet       Date:  2022-02-10       Impact factor: 41.307

Review 4.  The contributions of extrachromosomal DNA elements in neoplasm progression.

Authors:  Jiawei Hong; Shusen Zheng; Donghai Jiang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

5.  Substituted Chromen-4-one Derivatives for Treating Hepatitis B Virus Infection.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-02-17       Impact factor: 4.345

6.  Novel Substituted 3,4-Dihydroquinazoline Derivatives for Treating Hepatitis B Virus Infection.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-06-04       Impact factor: 4.632

7.  Effects of nucleases on cell-free extrachromosomal circular DNA.

Authors:  Sarah Tk Sin; Jiaen Deng; Lu Ji; Masashi Yukawa; Rebecca Wy Chan; Stefano Volpi; Augusto Vaglio; Paride Fenaroli; Paola Bocca; Suk Hang Cheng; Danny Kl Wong; Kathy O Lui; Peiyong Jiang; K C Allen Chan; Rossa Wk Chiu; Y M Dennis Lo
Journal:  JCI Insight       Date:  2022-04-22

8.  ecDNA within tumors: a new mechanism that drives tumor heterogeneity and drug resistance.

Authors:  Xixi Zeng; Maoping Wan; Jianmin Wu
Journal:  Signal Transduct Target Ther       Date:  2020-11-24

Review 9.  Extrachromosomal circular DNA: a new potential role in cancer progression.

Authors:  Tianyi Wang; Haijian Zhang; Youlang Zhou; Jiahai Shi
Journal:  J Transl Med       Date:  2021-06-10       Impact factor: 5.531

Review 10.  Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance.

Authors:  Yuanliang Yan; Guijie Guo; Jinzhou Huang; Ming Gao; Qian Zhu; Shuangshuang Zeng; Zhicheng Gong; Zhijie Xu
Journal:  J Hematol Oncol       Date:  2020-09-14       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.